Menu

Surveying The CRISPR Patent War

Following this week’s oral argument at the U.S. Court of Appeals for the Federal Circuit, there has been a surge of interest in the long-running CRISPR patent dispute between the Regents of the University of California (with collaborators the University of Vienna and Emmanuelle Charpentier) and the Broad Institute (with collaborators Harvard and MIT). This article summarizes the broader patent war between those two sides and addresses its potential implications for others seeking to use CRISPR-based technologies.


Click here for a PDF of the full text